OCC — Orthocell Cashflow Statement
0.000.00%
- AU$335.58m
- AU$305.40m
- AU$6.76m
- 59
- 15
- 94
- 59
Annual cashflow statement for Orthocell, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 3.02 | 2.95 | 2.23 | 25.2 | 3.87 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -5.26 | -4.52 | -6.26 | 14.6 | -6.51 |
Capital Expenditures | -0.055 | -0.189 | -0.535 | -0.632 | -0.942 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.055 | -0.189 | -0.535 | -0.632 | -0.942 |
Financing Cash Flow Items | -0.66 | — | — | — | -0.123 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.5 | 0.594 | 1.49 | -0.165 | 3.24 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.21 | -4.11 | -5.31 | 13.8 | -4.2 |